Krynica Vitamin S.A. (WSE:KVT)
12.70
+0.50 (4.10%)
Apr 28, 2026, 3:50 PM CET
Krynica Vitamin Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 356.27 | 387.89 | 357.12 | 377.16 | 395.31 | Upgrade
|
| Other Revenue | - | - | - | - | 0 | Upgrade
|
| Revenue | 356.27 | 387.89 | 357.12 | 377.16 | 395.31 | Upgrade
|
| Revenue Growth (YoY) | -8.15% | 8.62% | -5.31% | -4.59% | -11.35% | Upgrade
|
| Cost of Revenue | 295.75 | 323.54 | 304.63 | 310.91 | 336.78 | Upgrade
|
| Gross Profit | 60.53 | 64.36 | 52.49 | 66.25 | 58.53 | Upgrade
|
| Selling, General & Admin | 40.61 | 48.5 | 44.66 | 44.87 | 40.28 | Upgrade
|
| Other Operating Expenses | -1.69 | -3.34 | -0.77 | 0.51 | -5.14 | Upgrade
|
| Operating Expenses | 38.92 | 45.17 | 43.88 | 45.38 | 35.15 | Upgrade
|
| Operating Income | 21.61 | 19.19 | 8.61 | 20.88 | 23.39 | Upgrade
|
| Interest Expense | -2.07 | -3.62 | -4.32 | -3.56 | -0.91 | Upgrade
|
| Interest & Investment Income | 0 | 0 | 0 | 0 | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.27 | 0.62 | 0.62 | 1.02 | 1.3 | Upgrade
|
| EBT Excluding Unusual Items | 19.82 | 16.19 | 4.91 | 18.34 | 23.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.07 | 0.04 | 0.09 | -0.05 | -0.06 | Upgrade
|
| Asset Writedown | -5.06 | -2.42 | 0.37 | -4.14 | -2.8 | Upgrade
|
| Other Unusual Items | - | - | -12.1 | - | - | Upgrade
|
| Pretax Income | 14.83 | 13.81 | -6.74 | 14.15 | 21 | Upgrade
|
| Income Tax Expense | 2.88 | 1.58 | -0.05 | 1.07 | 5.42 | Upgrade
|
| Net Income | 11.95 | 12.23 | -6.68 | 13.08 | 15.58 | Upgrade
|
| Net Income to Common | 11.95 | 12.23 | -6.68 | 13.08 | 15.58 | Upgrade
|
| Net Income Growth | -2.29% | - | - | -16.05% | -72.63% | Upgrade
|
| Shares Outstanding (Basic) | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 12 | 12 | 12 | 12 | 12 | Upgrade
|
| Shares Change (YoY) | -0.02% | - | - | - | - | Upgrade
|
| EPS (Basic) | 0.98 | 1.00 | -0.55 | 1.07 | 1.27 | Upgrade
|
| EPS (Diluted) | 0.98 | 1.00 | -0.55 | 1.07 | 1.27 | Upgrade
|
| EPS Growth | -2.27% | - | - | -16.05% | -72.63% | Upgrade
|
| Free Cash Flow | 24.75 | 20.19 | 13.68 | -1.75 | -7.41 | Upgrade
|
| Free Cash Flow Per Share | 2.02 | 1.65 | 1.12 | -0.14 | -0.60 | Upgrade
|
| Dividend Per Share | - | 0.270 | - | 0.200 | - | Upgrade
|
| Gross Margin | 16.99% | 16.59% | 14.70% | 17.57% | 14.81% | Upgrade
|
| Operating Margin | 6.07% | 4.95% | 2.41% | 5.54% | 5.92% | Upgrade
|
| Profit Margin | 3.35% | 3.15% | -1.87% | 3.47% | 3.94% | Upgrade
|
| Free Cash Flow Margin | 6.95% | 5.21% | 3.83% | -0.46% | -1.87% | Upgrade
|
| EBITDA | 36.11 | 32.81 | 22.79 | 33.53 | 35.94 | Upgrade
|
| EBITDA Margin | 10.14% | 8.46% | 6.38% | 8.89% | 9.09% | Upgrade
|
| D&A For EBITDA | 14.5 | 13.62 | 14.18 | 12.66 | 12.55 | Upgrade
|
| EBIT | 21.61 | 19.19 | 8.61 | 20.88 | 23.39 | Upgrade
|
| EBIT Margin | 6.07% | 4.95% | 2.41% | 5.54% | 5.92% | Upgrade
|
| Effective Tax Rate | 19.40% | 11.44% | - | 7.55% | 25.81% | Upgrade
|
| Revenue as Reported | 356.27 | 387.89 | 357.12 | 377.16 | 395.31 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.